"Carcinogenicity Tests" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tests to experimentally measure the tumor-producing/cancer cell-producing potency of an agent by administering the agent (e.g., benzanthracenes) and observing the quantity of tumors or the cell transformation developed over a given period of time. The carcinogenicity value is usually measured as milligrams of agent administered per tumor developed. Though this test differs from the DNA-repair and bacterial microsome MUTAGENICITY TESTS, researchers often attempt to correlate the finding of carcinogenicity values and mutagenicity values.
| Descriptor ID |
D015197
|
| MeSH Number(s) |
E05.940.150
|
| Concept/Terms |
Carcinogenicity Tests- Carcinogenicity Tests
- Carcinogenicity Test
- Test, Carcinogenicity
- Tests, Carcinogenicity
- Carcinogenesis Tests
- Carcinogenesis Test
- Test, Carcinogenesis
- Tests, Carcinogenesis
- Tumorigenicity Tests
- Test, Tumorigenicity
- Tests, Tumorigenicity
- Tumorigenicity Test
- Carcinogenic Potency Tests
- Carcinogenic Potency Test
- Potency Test, Carcinogenic
- Potency Tests, Carcinogenic
- Test, Carcinogenic Potency
- Tests, Carcinogenic Potency
- Carcinogen Tests
- Carcinogen Test
- Test, Carcinogen
- Tests, Carcinogen
- Carcinogenic Activity Tests
- Carcinogenic Activity Test
- Test, Carcinogenic Activity
- Tests, Carcinogenic Activity
|
Below are MeSH descriptors whose meaning is more general than "Carcinogenicity Tests".
Below are MeSH descriptors whose meaning is more specific than "Carcinogenicity Tests".
This graph shows the total number of publications written about "Carcinogenicity Tests" by people in this website by year, and whether "Carcinogenicity Tests" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 2 | 2 |
| 1998 | 0 | 3 | 3 |
| 2001 | 2 | 0 | 2 |
| 2002 | 0 | 1 | 1 |
| 2003 | 1 | 1 | 2 |
| 2006 | 0 | 2 | 2 |
| 2007 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
| 2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Carcinogenicity Tests" by people in Profiles.
-
Targeting 4-1BB costimulation to the tumor stroma with bispecific aptamer conjugates enhances the therapeutic index of tumor immunotherapy. Cancer Immunol Res. 2014 Sep; 2(9):867-77.
-
Identification of cancer stem cells in human gastrointestinal carcinoid and neuroendocrine tumors. Gastroenterology. 2011 Nov; 141(5):1728-37.
-
Valproic Acid prolongs survival time of severe combined immunodeficient mice bearing intracerebellar orthotopic medulloblastoma xenografts. Clin Cancer Res. 2006 Aug 01; 12(15):4687-94.
-
Abnormal expression of REST/NRSF and Myc in neural stem/progenitor cells causes cerebellar tumors by blocking neuronal differentiation. Mol Cell Biol. 2006 Mar; 26(5):1666-78.
-
Mutagen-induced chromatid breakage as a marker of cancer risk. Methods Mol Biol. 2005; 291:59-67.
-
Antitumor activity of IFIX, a novel interferon-inducible HIN-200 gene, in breast cancer. Oncogene. 2004 Jun 03; 23(26):4556-66.
-
Estimation of k for the poly-k test with application to animal carcinogenicity studies. Stat Med. 2003 Aug 30; 22(16):2619-36.
-
Increased expression of TATA-binding protein, the central transcription factor, can contribute to oncogenesis. Mol Cell Biol. 2003 May; 23(9):3043-51.
-
Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis. Oncogene. 2003 Jan 23; 22(3):319-29.
-
Wild type p53 sensitizes soft tissue sarcoma cells to doxorubicin by down-regulating multidrug resistance-1 expression. Cancer. 2001 Sep 15; 92(6):1556-66.